Company / Shareholders' Equity
BioAtla, Inc. Shareholders' Equity History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$180.3M
FY2022
5-year range
$180.3M / $210.8M
FY2021-FY2022
Trend
-14.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$180M in FY2022.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, shareholders' equity decreased 14.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $180.3M | -14.5% |
| FY2021 | $210.8M | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026